
Company Information
Ask for more detail from the seller
Contact SupplierSecukinumab is used to treat psoriasis, ankylosing spondylitis, and psoriatic arthritis.[4][5][6][7] It is given by subcutaneous injection and is sold in a pre-filled syringe or autoinjector that can be used at home and as a lyophilized powder for use in hospitals and clinics.[5] In October 2023, the FDA approved an intravenous variant of secukinumab.[8]
Secukinumab was not tested in pregnant women; animal studies did not show harm at relevant doses. The US Food and Drug Administration advises that the drug should be used in pregnant women only if the risk to the fetus is justified by the potential benefit;[5] the European Medicines Agency (EMA) advises that women should not become pregnant while taking it.